10x Genomics, Inc. (TXG): Capital Expenditures
$5.93M
Year ended 2025-12-31
$5.65M
Trailing 12 months to 2026-06-30
-64.4%
3-year compound annual growth
-30.5%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.93M | -52.1% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $12.39M | -74.5% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $48.60M | -63.1% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $131.66M | +30.0% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $101.28M | +176.2% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $36.67M | -14.2% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $42.74M | +580.2% | 2022-02-18, From 2019-01-01 |
| 2018-12-31 | $6.28M | +67.3% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $3.76M | n/a | 2020-02-27, From 2017-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $5.93M | -52.1% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $4.08M | +15.9% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $2.71M | -56.1% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $157.60M | -4.8% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $73.52M | -15.1% |
| Quanterix Corp (QTRX) | 2025-12-31 | $2.61M | -22.4% |
| Waters Corp (WAT) | 2025-12-31 | $112.75M | -20.9% |
| Bruker Corp (BRKR) | 2025-12-31 | $90.80M | -21.2% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $107.12M | +3.1% |
Compare TXG, CTKB, PACB, BIO side by side · Screen every company in Laboratory Analytical Instruments ↗